CAR-NK:让细胞免疫疗法惠及大众——《自然》杂志报道
CAR-NK: bringing cellular immunotherapy to the masses - Nature
生物技术与制药领域的最新动态
CAR-NK: bringing cellular immunotherapy to the masses - Nature
When Inherency Meets Obvious-to-Try: How Cytiva V. JSR Clarifies The Patent Obviousness Analysis - Mondaq
Federal Circuit Says No Expectation of Success Required to Combine Inherent Property of Compound with Prior Art - IPWatchdog.com
JSR Corp. Wipes out Cytiva Antibody Tech Patents at Federal Cir. - Bloomberg Law News
Cytiva strengthens APAC presence with Korea plant - BioProcess International
Cytiva Introduces FlexFactory to Poland - GEN - Genetic Engineering and Biotechnology News
Cytiva seeks tax incentive for expansion plans - Community Advocate
Ins & Outs: Repligen and Cytiva welcome new leaders - BioProcess International
Cytiva Launches Next-Gen Cell Therapy Manufacturing Platform - GEN - Genetic Engineering and Biotechnology News
Cytiva rolls out new CAR-T manufacturing platform developed with Gilead's Kite - Fierce Pharma
Cytiva Introduces ELEVECTA Cell Lines - Contract Pharma
Cytiva Introduces Its Xcellerex Magnetic Mixer at Interphex - GEN - Genetic Engineering and Biotechnology News
Cytiva's tech to bolster capacity at White Raven's Belgium site - BioProcess International
Cytiva acquires Michigan plant from BASF - BioProcess Insider - BioProcess International
Cytiva doubles liquid cell culture media capacity with Intermountain bolt-on - BioProcess International
Cytiva pumps further $47m into Welsh single-use site - BioProcess International
Introducing Cytiva: GE plans name change ahead of $21bn Danaher buy - BioProcess International
Filling in its drug product offering: Cytiva buys Vanrx Pharmasystems - BioProcess International
Cytiva bolsters CDMO business with MA expansion - BioProcess International
Cytiva snaps up Cevec, boosting cell line and viral vector services - BioProcess International